• 1. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Acetanilides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Anilides Acetanilides

2-Acetamido-5-aminophenylboronic Acid (CAS No. 136237-84-8): A Comprehensive Overview

2-Acetamido-5-aminophenylboronic Acid (CAS No. 136237-84-8) is a versatile compound with significant applications in various fields, including medicinal chemistry, bioconjugation, and materials science. This compound is characterized by its unique structure, which includes an acetamido group and an aminophenylboronic acid moiety, making it a valuable reagent in the synthesis of complex molecules and the development of novel therapeutic agents.

The acetamido group in 2-Acetamido-5-aminophenylboronic Acid provides the molecule with enhanced solubility and stability, while the aminophenylboronic acid moiety offers reactive sites for conjugation and functionalization. This combination of properties makes 2-Acetamido-5-aminophenylboronic Acid an ideal candidate for a wide range of applications, from drug discovery to the development of advanced materials.

In the field of medicinal chemistry, 2-Acetamido-5-aminophenylboronic Acid has been extensively studied for its potential as a building block in the synthesis of boron-containing drugs. Boron-based compounds have gained significant attention due to their unique biological activities and therapeutic potential. Recent research has shown that boronic acids can act as potent inhibitors of various enzymes, including proteases and kinases, which are often implicated in disease pathways.

One notable application of 2-Acetamido-5-aminophenylboronic Acid is in the development of boron neutron capture therapy (BNCT) agents. BNCT is a promising cancer treatment modality that involves the selective accumulation of boron-containing compounds in tumor cells followed by irradiation with thermal neutrons. The boron atoms capture neutrons and undergo nuclear fission, releasing high-energy alpha particles that can selectively destroy cancer cells while minimizing damage to surrounding healthy tissue. 2-Acetamido-5-aminophenylboronic Acid has been explored as a potential BNCT agent due to its ability to selectively target tumor cells and its high boron content.

In addition to its therapeutic applications, 2-Acetamido-5-aminophenylboronic Acid has also found use in bioconjugation chemistry. The reactive boronic acid group can form stable covalent bonds with various biomolecules, such as sugars, proteins, and nucleic acids. This property makes 2-Acetamido-5-aminophenylboronic Acid an excellent reagent for the synthesis of bioconjugates with specific biological functions. For example, it can be used to attach targeting ligands to drug molecules or to create functionalized nanoparticles for drug delivery.

The synthesis of 2-Acetamido-5-aminophenylboronic Acid typically involves multi-step reactions starting from readily available starting materials. One common synthetic route involves the reaction of 4-acetamidophenylboronic acid with hydrazine hydrate to form the desired product. The resulting compound can be further modified through various chemical transformations to introduce additional functional groups or enhance its properties for specific applications.

Recent advancements in analytical techniques have also contributed to a better understanding of the properties and behavior of 2-Acetamido-5-aminophenylboronic Acid. High-resolution mass spectrometry (HRMS) and nuclear magnetic resonance (NMR) spectroscopy are commonly used to characterize the compound and monitor its reactions. These techniques provide detailed information about the molecular structure and dynamics, which is crucial for optimizing synthetic protocols and developing new applications.

The safety profile of 2-Acetamido-5-aminophenylboronic Acid is another important consideration in its use. While boron-based compounds are generally considered safe at low concentrations, it is essential to follow proper handling and storage procedures to ensure their stability and prevent degradation. Additionally, toxicological studies have shown that 2-Acetamido-5-aminophenylboronic Acid exhibits low toxicity in vitro and in vivo, making it a suitable candidate for further development in pharmaceutical applications.

In conclusion, 2-Acetamido-5-aminophenylboronic Acid (CAS No. 136237-84-8) is a multifaceted compound with a wide range of applications in medicinal chemistry, bioconjugation, and materials science. Its unique structural features and reactive properties make it an invaluable reagent for the synthesis of complex molecules and the development of novel therapeutic agents. Ongoing research continues to uncover new possibilities for this compound, highlighting its potential as a key player in advancing scientific knowledge and improving human health.

• 169760-16-1((2-Acetamidophenyl)boronic acid)
• 78887-39-5((3-acetamidophenyl)boronic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)